A new synthesis of (R, S)-PPG (4-phosphonophenylglycine) and the separation of the protected enantiomers leading after deprotection to (+)-and (−)-PPG are described. Pharmacological characterization at the group III metabotropic glutamate receptors hmGluR4a and hmGluR7b revealed (+)-PPG as the active enantiomer.
